2025 annual financial data
ACADIA Pharmaceuticals 2025 Operating margin
ACADIA Pharmaceuticals 2025 operating margin with verified reported values.
Direct answer
Operating margin was 9.78%.
Operating income was 104,811,000 USD and net income was 391,000,000 USD.
Operating cash flow was 109,836,000 USD.
Get free ACADIA Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 1,071,505,000 USD
- Operating income
- 104,811,000 USD
- Net income
- 391,000,000 USD
- Operating cash flow
- 109,836,000 USD